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Abstract
Background: The collaborative treatment of acupuncture in addition to routine care as an approach for the
management of low back pain (LBP) is receiving increasing recognition from both public and professional arenas.
In 2010, the Ministry of Health, Welfare and Family Affairs (MOHW) of South Korea approved the practice of doctors
and Oriental medical doctors (acupuncture qualified) working together in the same facility and offering
collaborative treatment at the same time for the same disease. However, there is little more than anecdotal
evidence on the health and economic implications of this current practice. Therefore, the objective of this study is
to examine the effectiveness and costs of acupuncture in addition to routine care in the treatment of chronic LBP
patients in South Korea.
Methods: The Markov model was developed to synthesise evidence on both costs and outcomes for patients with
chronic LBP. We conducted the base case analysis, univariate and probabilistic sensitivity analyses, and also
performed the value of information analysis for future researches. Model parameters were sourced from systematic
review of both alternatives, simple bibliographic reviews of relevant articles published in English or Korean, and
statistical analyses of the 2005 and 2007 Korean National Health and Nutrition Survey (KNHNS) data. The analyses
were based on the societal perspective over a five year time horizon using a 5% discount rate.
Results: In the base case, collaborative treatment resulted in better outcomes, but at a relatively high cost. Overall,
the incremental cost-effectiveness ratio of a collaborative practice was 3,421,394 KRW (Korean rate Won) per QALY
(Quality adjusted life year) (2,895.80 USD per QALY). Univariate sensitivity analysis of indirect non-medical costs did
not affect the preference order of the strategies. Probabilistic sensitivity analysis revealed that if the threshold was
over 3,260,000 KRW per QALY (2,759.20 USD per QALY), the probability for cost-effectiveness of a collaborative
practice would exceed 50%. At 20,000,000 KRW per QALY, which is recommended using per capita gross domestic
product (GDP) as the threshold, the probability would be 72.3%.
Conclusions: On the basis of our findings, acupuncture collaborative therapy for patients with chronic LBP may be
cost-effective if the usual threshold is applied. Further empirical studies are required to overcome the limitations of
uncertainties and improve the precision of the results.
Background
Numerous studies in various countries attest to the high
frequency of low back pain (LBP). Approximately 70-85%
of all people have back pain at some point in their life-
time, and the annual prevalence ranges from 15% to 45%,
with point prevalence averaging 30%. Nearly 80-90% of
patients with back pain recover quickly within 12 weeks,
but recovery after 12 weeks is slow and uncertain [1].
Chronic LBP is defined as LBP that persists or recurs
over 12 weeks [1,2]. A 2007 Korean National Health and
Nutrition Survey (KNHNS) data analysis showed that
over 6.5% of adults experience chronic LBP [3]. Chou
et al. [4] stated that there has been little consensus on
the management of LBP, and the development of clinical
practice guidelines based on available evidence is
necessary.
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ment, compared to usual care alone, has proved to be
cost-effective [5,6]. However, some parameters, such as
natural mortality rates, medical costs and national
threshold, which are necessary in the analyses, differ
from country to country. Therefore, cost-effectiveness
results may also vary by medical institution and condi-
tions; an economic evaluation should be conducted for
each situation [7].
Decision analytic modelling is a systematic approach
to decision making under uncertainty that is widely
used in economic evaluations of pharmaceuticals and
other health care technologies [7]. Despite the concerns
about the methodologies of economic evaluation [8],
decision analytic modelling is used to synthesise the
best available data and conduct economic evaluations,
especially when no optimal cost-effective analytic out-
come from clinical trials has yet been established [9].
Recently, the Korean Ministry of Health, Welfare and
Family Affairs (MOHW) launched several laws concern-
ing medical provider employment and collaboration.
Under these laws, doctors and Oriental medical doctors
(acupuncture qualified) can work together in the same
facility and offer collaborative treatment at the same time
for the same disease [10]. Until 2009 in South Korea,
these types of collaborations were indirectly regulated by
the limited reimbursing regulation of Health Insurance
Review and Assessment service (HIRA). Therefore, there
is a possible increase in chronic LBP cases that are trea-
ted with collaborative treatment in addition to the usual
practice.
The purpose of this study is to examine the cost-effec-
tiveness of usual care and acupuncture collaboration as
compared to usual care alone, and to provide informa-
tion about the level of improvement required to sub-
stantially alter the cost-effectiveness of the therapeutic
decision in South Korea. We also conducted a value of
information analysis, using the net monetary benefit and
population expected value of perfect information (EVPI),
to provide a rational background for future research
investments.
Methods
Treatment regimen
Usual Care
The American College of Physicians and the American
Pain Society (ACP&APS) promoted clinical practice
guidelines for chronic LBP, that achieve at least grade B
results (medium benefit and/or no harm) according to
prior research [11]. The interventions listed in the guide-
line include self-care (remain active, hand out books and
apply superficial heat), pharmacological therapies (aceta-
minophen, NSAIDs, antidepressants, benzodiazepines
and opioids) and non-pharmacologic therapies (spinal
manipulation, exercise therapy, massage, acupuncture,
yoga, cognitive-behavioural therapy, progressive relaxa-
tion and intensive interdisciplinary rehabilitation).
Among these interventions, orthopaedic and rehabilita-
tion specialists in a general hospital were asked for com-
mon prescriptions that have been established as
generalised ‘usual care’ lists used in South Korea. These
interventions included NSAIDs, heat therapy, electro-
therapy and lumbar traction (Table 1).
Usual care and acupuncture collaboration
The definition of collaboration in this study is that the
usual care provided by medical doctors, and the acupunc-
ture treatment provided by licensed Oriental medicine
doctors, are collaboratively offered to patients at the same
time in the same hospital. Because clinical studies regard-
ing the usual care and acupuncture collaborative treat-
ment of chronic LBP in South Korea have not been
conducted, we systematically reviewed the papers and
derived the effectiveness results (Appendix 1-2). We also
found similarities within the acupuncture treatment proto-
cols from the systematic review results (Table 2), and
assumed that the effectiveness of acupuncture by Oriental
medicine doctors would be the same based on Cherkin
et al.’s result [12].
Model Structure
We constructed a Markov model and conducted the
analyses based on the references using available soft-
ware, Microsoft Excel 2007 [13]. Treatment regimens
were compared as defined above and we assumed that
there were 10 treatment sessions per cycle.
Markov states were acute LBP, chronic LBP, Well, and
Death states (Figure 1). The cohort of patients was
assumed to be 60-year-old females, who recorded the
highest prevalence rate of suffering from their first
experience of acute LBP according to the 2007 KNHNS
results. Individuals who experienced LBP for the first
time for no more than three months were included in
the initial acute LBP state.
Patients, for whom the pain lasted over three months in
the initial acute LBP state, were transitioned to chronic
LBP. Those patients who recovered from acute LBP and
chronic LBP moved to the Well state. If the pain reoc-
curred in the Well state, they were retransferred to the
chronic LBP state. Cases in all states could be transferred
to the Death state based on age- and sex-specific all-
cause mortality rates derived from South Korean life
tables [14]. The effectiveness of acupuncture for acute
LBP has not yet been proven [15-17], therefore we
assumed that the patients of both treatment groups in
the acute LBP state were equally treated by usual care,
and were excluded from the analysis.
The analyses were based on a societal perspective over a
five-year time horizon using a 5% discount rate. We
Kim et al. BMC Complementary and Alternative Medicine 2010, 10:74
http://www.biomedcentral.com/1472-6882/10/74
Page 2 of 12Table 1 Definitions of procedures and medical costs (KRW in 2009) 24
Procedure First visit Regular visit for diagnosis and
treatment
Simple regular visit for
treatment
Treatment Cost Treatment Cost Treatment Cost
Usual Care First medical examination 14,730 Recursive medical
examination
11,080 Hospital
management fee
3,110
Diagnostic testing 18,648 Diagnostic testing 7,510 Physical treatment 7,439
Pharmacy cost 7,510 Pharmacy cost 5,650
Drug cost 5,650 Drug cost 7,439
Physical therapy 7,439 Physical therapy 31,685
Frequency 1 time 53,983 6 times 31,685 3 times 10,549
Direct medical costs for usual care during 3 months in the chronic LBP state. 275,740
First medical examination 14,730 Recursive medical
examination
11,080 Hospital
management fee
3,110
Usual Care and Acupuncture
Collaborative Treatment
First oriental medical
examination
9,980 Recursive oriental medical
examination
6,300 Physical treatment 6,300
Collaborative examination 4,120 Collaborative examination 4,210 General
acupuncture
7,439
Pharmacy cost 7,510 Pharmacy cost 7,510 Special spine
acupuncture
4,212
Drug cost 5,650 Drug cost 5,650 3,816
Physical therapy 7,439 Physical therapy 7,439
General acupuncture 4,212 General acupuncture 4,212
Special spine acupuncture 3,816 Special spine acupuncture 3,816
Frequency 1 time 57,463 6 times 50,223 3 times 24,877
Direct medical costs for collaboration during 3 months in the chronic LBP state. 433,434
Pharmacy cost: pharmacy management (14 days) + prescription cost + medication teaching cost + pharmaceutical cost Physical treatment: Hot pack, TENS,
traction
Table 2 Acupuncture protocols for chronic low back pain in the papers
Paper and study
type
Nation Type of acupuncture Theory and
rationale
Treatment area and
acupuncture points
Treatment
sessions
Treatment
duration
(min)
Carlsson (2001)
RCT [30]
Sweden Disposable, stainless steel, diameter
between 0.30 mm and 0.32 mm,
length between 30 mm and 70 mm
Not-
mentioned
Lower back lower limbs, forearms
or hands (Bladder and large
intestine acupuncture points)
8 session
per 8
weeks
20 minutes
Leibing (2002)
RCT [34]
Germany Wrapped one-way stainless steel,
sterilised needle diameter 0.30 mm
length40 mm
Traditional
Chinese
medicine
Body and ear (Governor Vessel,
bladder, gall bladder, spleen
acupuncture points)
20 session
per 12
weeks
30 minutes
Kerr (2003) RCT
[32]
Northern
Ireland
Not-mentioned Not-
mentioned
Bladder, gall bladder, kidney
meridian and governor vessel
acupuncture points
6 session
per 6
weeks
30 minutes
Meng (2003) [35] USA Disposable, sterile 30-gauge needles Traditional
Chinese
medicine
Urinary bladder meridian 10 session
per 5
weeks
Not-
mentioned
Thomas (2006)
Pragmatic
RCT [25]
UK Sterilised, disposable needle, needle
length and diameter were not
predefined
Not-
mentioned
Bladder, gall bladder meridian
acupuncture points
10 session
per 3
months
Not-
mentioned
Brinkhaus (2006)
RCT [29]
Germany Sterile, disposable needle length 50
mm
Not-
mentioned
bladder, governor Vessel, small
intestine, bladder, kidney, gall
bladder meridian acupuncture
points
12 session
per 8
weeks
30 minutes
Kwon
RCT (2007) [33]
S. Korea Disposable stainless needle Donguibogam Gall bladder, small intestine,
bladder meridian acupuncture
points
12 session
per 4
weeks
20 minutes
HIRA (2009) [30] S. Korea 40 mm length, 0.30 mm width,
stainless steel metal
Acupuncture
(Textbook)
Bladder, Du mai channel, small
intestine, gallbladder, channel etc.
Not-
mentioned
20 minutes
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Page 3 of 12defined the time horizon according to the revision sche-
dule of National Health Insurance Medical Costs and the
discount rate based on the reference case recommendation
of the Panel on Cost-Effectiveness in Health and Medicine
and the Guidelines of Economic Evaluation of Medical
Supplies in South Korea [18].
All monetary costs were converted to 2009 Korean
rate Won (KRW) using the South Korean Consumer
Price Index [19]; exchange rates used in the analysis
were in accordance with the 2009 Korean Exchange
R a t e s( 1U S D=1 , 1 8 1 . 5 0K R W )[ 2 0 ] .T h eM a r k o vc y c l e
length was three months and the time horizon was
twenty cycles. Effectiveness obtained from both alterna-
tives was calculated using quality adjusted life year
(QALY) to account for changes in quality of life (QOL).
Key assumptions for construction of the model are listed
under each component below and all source data are
openly available in the mentioned databases.
Model Estimation
Transition Probabilities
Probabilities from the initial state to the chronic LBP
and Well state were estimated from a perspective cohort
s t u d yb yG r o t l ee ta l . ,i nw h i c ht h ef i r s t - t i m ep a t i e n t s
consulted primary care due to an episode of acute LBP.
Of this group, 24% still experienced LBP after three
months [21]. We assumed that the recurrence of LBP in
the Well state is considered as chronic LBP. The recur-
rence rate was derived from the Cassidy et al. study
[22]. The recurrence rate of 6 months in the study is
converted to the transition probability of 3 months
using the following formulae [23]:
Probability 1 exp Rate time
Rate ln 1 Probability
=− − ×
=− − () ⎡ ⎣ ⎤ ⎦
() ,
/t time
The different transition probabilities of both alternatives
from chronic LBP to Well state were obtained from a sys-
tematic review and meta-analysis results. Considering the
development of medical technologies and supplies, we
defined the review period as 10 years from January 1999
to January 2009. The flow diagram of the systematic
review is described in Figure 2, and the meta-analysis
results are shown in Figure 3. Because the studies included
in the meta-analysis are from different countries, we used
the random effect model to overcome the heterogeneity.
From the analysis, we achieved the difference of transition
probabilities between two alternatives as a risk ratio of
1.40. All transition probabilities are described in Table 3
and the transition matrix is defined in Table 4.
Utilities
Estimate of acute LBP and Well state utilities were
derived from a subgroup analysis of 2007 KNHNS data.
No domestic research results estimating the utilities of
Figure 1 Markov model of chronic low back pain.
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Page 4 of 12chronic LBP were identified, thus we estimated separate
utilities for the usual care and acupuncture collaboration
groups from the Witt et al. study [5]. All states’ QOLs
are listed in Table 3.
Costs
Direct costs of both alternatives for 1 cycle (3 months) in
chronic LBP were obtained from the South Korean
National Health Insurance Reimbursement for standard
medical procedures [24], and frequencies were derived
from pragmatic trial results [5,25]. Direct non-medical
costs, such as traffic expenses, waiting times, and treat-
ment times obtained from the 2005 KNHNS data analysis
were included in the cost simulation [26]. All medical
costs for both alternatives are listed in Table 1. Direct
non-medical costs and indirect non-medical costs were
obtained using sources and formulae as described in
Table 5. The costs of the acute LBP and Well states were
excluded, based on the assumptions firstly that the treat-
ment for acute LBP would be the same, and secondly
that no treatment would be required in the Well state.
Statistics and Analyses
Deterministic analyses, univariate and probabilistic sen-
sitivity analyses were performed. In the deterministic
analysis, we entered the mean values of the parameters
and calculated the incremental cost-effectiveness ratio
(ICER) of both alternatives. Recently, when using
Q A L Y sa st h ed e n o m i n a t o r ,w h e t h e rt oi n c l u d et h e
indirect non-medical costs in the analysis has become
debatable [18,27]. Therefore, in the base case analysis,
we excluded the indirect non-medical costs from the
analysis, and then examined whether including these
costs could alter the cost-effectiveness result using uni-
variate sensitivity analysis.
Figure 3 Meta-analysis of the risk ratio (transition probability).
Figure 2 Systematic review flow diagram.
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were varied simultaneously over their listed range, with
10,000 recalculations of net benefits using random
draws from their distributions, as shown in Table 3.
In addition, we calculated the population EVPI using
probabilistic sensitivity analysis results over a 5-year time
horizon, assuming 57,400 cases per year, calculated from
the 2007 KNHNS data. The EVPI estimates the value of
eliminating uncertainty in all parameters and is calcu-
lated by subtracting the expected net benefit of adopting
an intervention based on current information from the
expected net benefit with perfect information. The EVPI
is the maximum that decision makers should be willing
to pay to resolve uncertainty about the adoption of an
intervention. In this context, when launching certain
research projects, the EVPI calculation determines
whether it is worthwhile to resolve the uncertainty.
Table 3 Parameter values and distributions examined in sensitivity analyses
Variable groups Name (Citation) ’Live’
value
Probabilistic Deterministic Standard
error
Distribution alpha beta
Transition probability(Tp)
variables
tATC [21] 0.24 0.04 0.24 28.773 Gamma/
Normal
29 91
tATW [21] 0.76 0.13 0.76 86.328 Gamma/
Normal
91 29
tWTC [22] 0.16 0.04 0.16 28.410 Gamma/
Normal
26 137
tWTW [22] 0.84 0.21 0.84 159.883 Gamma/
Normal
137 26
tCTW [31] 0.35 0.32 0.35 0.024 Beta 135 252
Resource cost parameters cUC [41] 507,776
KRW
543,520 KRW 494,071 KRW 507,776 KRW Gamma 24.69 20566.20
cACUC [41] 730,329KRW 706,676 KRW 682,759 KRW 730,329 KRW Gamma 19.54 37372.18
Utility of Markov states per
cycles
uALBP [3] 0.85 0.95 0.85 0.15 Beta 3.97 0.70
uCLBPUC [5] 0.62 0.68 0.62 0.10 Beta 13.99 8.57
uCLBPACUC [5] 0.65 0.70 0.65 0.10 Beta 14.14 7.61
uWell [3] 0.96 0.93 0.96 0.04 Beta 22.08 0.92
Recovery rate of chronic LBP tRR (Fig. 2) 1.40 1.31 1.40 Log normal 0.34
(Ln-mean)
0.05
(Ln-SE)
TP parameters
tATC: TP acute LBP to chronic LBP state, tATW: TP acute LBP to Well state, tWTC: TP Well to chronic LBP state, tWTW: TP Well to Well state, tCTW: TP chronic LBP
to Well state, Resource costs parameters
cUC: costs used in chronic LBP state treated by usual care, cACUC: costs used in chronic LBP state treated by collaborationUtility parameters
uALBP: QOL of acute LBP state, uCLBPUC: QOL of chronic LBP state treated by usual care, uCLBPACUC: QOL of chronic LBP state treated by collaboration, uWell:
QOL of Well stateRecovery rate
tRR: risk ratio of TP from chronic LBP to the Well state when treated by the collaboration compared with the usual care
Table 4 Transition matrix (Usual care)
Transition Matrix
aLBP cLBP Well Death
aLBP tATC = (1-mr) × 0.24 tATW = (1-mr) × 0.76 Mp
cLBP tCTC = (1-mr-tCTW) tCTW = (1-mr) × 0.35 Mp
Well tWTC = (1-mr) × 0.16 tWTW = (1-mr) × 0.84 Mp
Death
1) Mp (mortality probability) : South Korea Life Table
2) tATC, tATW: Grotle et al. (2005) [21]
3) tWTC, tWTW: Cassidy et al. (2007) [22]
4) tCTW: Haake et al. (2007) [31]
Table 5 Costs of 3 months in the chronic low back pain
state (KRW in 2009)
Strategy Cost (KRW)
Usual care
Direct medical costs 275,740
Direct non-medical costs 232,036
Indirect non-medical costs 239,142
Total cost for usual care 746,918
Collaborative treatment
Direct medical costs 433,432
Direct non-medical costs 296,897
Indirect non-medical costs 239,142
Total cost for collaborative treatment 969,471
Direct non-medical costs [26]: Hospital visiting time (15.64 min) + Treatment
time (Usual care - 60 min, Collaboration -90 min) + Traffic expenses (6,850
KRW)
Indirect non-medical costs [41]: Indirect cost of both alternatives = Average wage
per day (65,333 KRW) × Proportion of economically active person (0.614)×
Percentage of employment (0.586) × Number of treatment sessions (10)
Kim et al. BMC Complementary and Alternative Medicine 2010, 10:74
http://www.biomedcentral.com/1472-6882/10/74
Page 6 of 12Following Briggs et al.’s book [23], we used Microsoft
Office Excel 2007 to develop our model and conduct
the analyses. The systematic review and meta-analysis
were conducted using Review Manager 5. To obtain the
mean values and distributions of parameters, simple
descriptive statistics, Student’s t-test, and ANOVA were
executed using the Stata SE 10 program.
Results
Model calibration and validation
Before analysing the model, we tested the validity of the
Markov model to determine whether the results pro-
duced by the ‘usual care’ option reflect the real inci-
dence of chronic LBP. Because no comparable domestic
clinical cohort study result was found, we compared the
Canadian recurrence rates of 20% in 1 year and 36%
over 3 years [1]. The mean number of cases of chronic
LBP during the simulation periods revealed 2,982 cases
(95% confidence interval: 2,911-3,052) per 10,000 initial
state patients, and the point estimate of model outputs
after 5 years was 29.71% - close to the Canadian recur-
rence rate of 20% in 1 year and 36% over 3 years.
Deterministic analysis
In the base case, for the 10,000 60-year-old female
cohorts with acute LBP, the usual care resulted in a dis-
counted gain of 4.11 QALYs and cost of 2,988,203 KRW
per one person over 5 years. Collaborative treatment
resulted in a discounted gain of 4.24 QALYs and cost of
3,447,840 KRW. The ICER, which was derived from both
results, was 3,421,394 KRW per QALY (2,895.80 USD
per QALY) (Table 6). Because no absolute cost-effective-
ness criterion exists, we used WHO recommended guide-
lines, which suggest using per capita GDP (20,000,000
KRW) as the threshold for each country [28]. Therefore,
the ICERs for collaborative treatment versus usual care
are significantly less than the threshold. The cost-effec-
tiveness plane is displayed in Figure 4.
Sensitivity analysis
Univariate sensitivity analysis
We performed univariate sensitivity analysis of indirect
non-medical costs in the model. This analysis was con-
ducted to determine if adding the indirect costs to the
value of total costs would change the results of the ana-
lysis. Productivity loss of the patients was calculated
using the following formula:
Average wage  1day Proportion of economically active peop () × l le
Percentage of employment × .
The total indirect non-medical costs of both alterna-
tives were assumed as 239,142 KRW per 3 months.
Including indirect non-medical costs in the analysis did
Table 6 Deterministic analysis results (KRW in 2009)
Strategy Cost (KRW) Incremental cost Effectiveness (QALY) Incremental effectiveness Incremental C/E ratio
Usual care 2,988,203 - 4.11 - -
Collaborative treatment 3,447,840 459,637 4.24 0.13 3,421,394
Figure 4 ICER between two alternatives (deterministic result).
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described in Table 7.
Probabilistic sensitivity analysis
In the probabilistic sensitivity analysis, all parameters
were varied simultaneously in the ranges shown in
Table 3. Random draws from each parameter distribu-
tion were performed; then the cost-effectiveness of each
strategy was calculated. The procedure was repeated
10,000 times and we compared net monetary benefits of
both alternatives at the range of 0 to 20,000,000 KRW
of willingness to pay thresholds. Figure 5 displays the
results of the analyses in the form of a cost-effectiveness
acceptability curve (CEAC). This figure shows that if the
threshold is over 3,260,000 KRW, the cost-effectiveness
probability of collaborative treatment is higher than that
of usual care. Furthermore, when the threshold was
20,000,000 KRW per QALY, the probability of prefer-
ring collaborative treatment was 72.3%, which is higher
than usual care (26.3%).
Value of information analysis
The value of information analysis (VOIA) results are
displayed in Figure 6 as the maximum acceptable cost
per research subject, which is calculated by multiplying
the expected value of perfect information (EVPI) by the
expected population.
Table 7 Univariate sensitivity analysis of indirect cost (KRW in 2009)
Variable Indirect cost per 1 patient
(KRW)
Total cost per 1 cycle
(KRW)
Δ Cost per time
period
Δ QALY per time
period
Incremental C/E
ratio
Base case
Usual care 0 507,776
Collaborative
treatment
0 730,329 3,421,394 0.13 3,421,394
Inclusion of indirect
cost
Usual care 239,142 746,918
Collaborative
treatment
239,142 969,471 181,290 0.13 1,349,463
Δ Cost = Total cost of acupuncture collaboration - Total cost of usual care
Δ QALY = QALY gained with the acupuncture collaboration - QALY gained with the usual care
Figure 5 CEAC for chronic low back pain (probabilistic sensitivity analysis).
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threshold was 4,000,000 KRW, between 0 and 6,000,000
KRW. If the threshold increased to over 8,000,000
KRW, then the value of future research would exceed
120,000,000,000 KRW. According to this result, it would
be reasonable to fund future research that evaluates the
cost-effectiveness of collaborative treatment of acupunc-
ture and usual care.
Discussion
Recently, an increasing number of clinical research
concerning acupuncture for LBP has been conducted in
various countries [5,25,29-35]. In these papers, the
results do not provide firm conclusions about the effec-
tiveness of acupuncture for acute LBP. However, for
chronic LBP patients, acupuncture was assumed to be
effective for pain relief and functional improvement
[15-17,36]. Furland et al. in their systematic review, con-
cluded that acupuncture may be a useful adjunct to
other therapies for chronic LBP [15]. However, reimbur-
sement agents such as governments and insurers have
recently required evidence of economic benefit along
with clinical benefits to cover the treatments.
In 2010, the South Korean MOHW introduced several
laws regarding medical provider employment and colla-
boration, which allow medical doctors and Oriental
medical doctors (acupuncture qualified) to work together
in the same facility and offer simultaneous collaborative
treatment for the same disease. Previously, these types of
collaborations were indirectly regulated by the limited
reimbursing regulation of HIRA. These regulation
changes will increase the frequency of collaboration
between medical doctors and Oriental medical doctors;
however, whether the national health insurance will
cover this system is yet to be determined.
Therefore, we conducted this study to evaluate a colla-
boration of acupuncture and usual care for chronic LBP
patients in the newly developing medical environments
of South Korea.
Prior studies on this subject using patient level data have
been published in other countries. In the UK, Ratcliffe and
colleagues [6] conducted a pragmatic randomised clinical
trial (RCT) and examined the cost-effectiveness of the
addition of acupuncture treatment compared to usual care
alone. They calculated the ICER of acupuncture at 24
months as £4,241 per QALY (1£ = 1,944.16 KRW). They
concluded that assuming an implicit threshold of a maxi-
mum of willingness to pay of £20,000 per QALY, colla-
boration offers a modest health benefit for a minor extra
cost to the National Health Service (NHS).
Witt et al. [5] also published pragmatic RCT results in
Germany. In their study, they employed three arms of a
Figure 6 Population EVPI analysis result.
Kim et al. BMC Complementary and Alternative Medicine 2010, 10:74
http://www.biomedcentral.com/1472-6882/10/74
Page 9 of 12mixed model, two arms of randomised groups, and one
observational group, which were utilised to avoid the
selection bias of participant inclusion. If the participants
with severe LBP did not enter into the study and
attempt to be treated by most available treatments, then
the results would be exposed to a selection bias. There-
fore, in the analysis, the researchers were able to exam-
ine the selection bias by comparing characteristics of
randomised and non-randomised groups. Their results
showed that the ICER of acupuncture was €10,526 per
QALY (1€ = 1,742.12 KRW), and they concluded that
acupuncture collaboration was relatively cost-effective at
the threshold of €50,000.
These cost-effectiveness results, which are thought to be
based on different medical institutions and economic con-
ditions, could not be extrapolated to other countries.
Hutubessy et al addressed that the simple extrapolation
would be easy and quick, but it would result in misleading
answers and could encourage inefficient decisions [37].
While the two studies mentioned above conducted the
analyses using patient-level data from pragmatic RCTs, we
used a Markov model simulation to obtain the discounted
QALYs as a measure of effectiveness. The Markov model
format allowed us to evaluate the economic impact of
both alternatives over a five-year time horizon. The state
definitions of chronic LBP in previous clinical trials were
somewhat varying and confusing according to the purpose
of each research. Therefore, we defined chronic LBP as
persistent pain for 12 weeks or more, based on the clinical
practice guidelines published by the Agency for Health
Care Policy and Research (AHCPR) [38] and the Ques-
tionnaire of KNHNS 2007 [3].
The definition of ‘usual care’ could also vary based on
each country’s medical system. Although 54 clinical prac-
tice guidelines developed from South Korean medical
system were listed in the official database, the specific
guidelines for chronic LBP had not been established [39].
Therefore, we developed the questionnaire of usual care
intervention lists from the ACP&APS’ pharmacologic
and non-pharmacologic interventions which are regis-
tered in the international practice guideline database
[40]. Then we asked orthopaedic and rehabilitation spe-
cialists from a general hospital to identify the commonly
using procedures in South Korea. Based on the survey
results, we defined NSAIDs, heat therapy, electrotherapy
and lumbar traction as the ‘usual care’ in South Korea.
The effectiveness of additive acupuncture treatment
compared with usual care was derived from the
improvement of state QOL of chronic LBP and changed
transition probability to the Well state. The state QOL
of chronic LBP treated with both alternatives was
derived from the Witt et al. study results [5], and the
difference of transition probabilities to the Well state
was assumed from meta-analysis.
Although the effects come at a high cost, resulting in
a marginal cost effectiveness ratio of nearly 3,421,394
KRW per QALY, the costs are less than the generally
accepted societal threshold for willingness to pay at
20,000,000 KRW per QALY. In the probabilistic sensi-
tivity analysis, there was a 72.3% chance that collabora-
tive treatment would be cost-effective at a willingness to
pay threshold of 20,000,000 KRW per QALY. This result
indicates that for chronic LBP disease, acupuncture col-
laborative treatment could be acceptable to the National
Health Insurance reimbursement lists.
Several limitations of the present analysis should be con-
sidered when interpreting its results. First, we could not
include all available alternatives due to a lack of evidence.
Despite the fact that herbal medicines, cupping, and other
treatments are commonly used as alternative treatments
in South Korea, we could not find appropriate papers that
analysed the effectiveness of these alternatives. However,
Weinstein et al. wrote that the ability of the model to
make accurate predictions of future events is valuable, but
not absolutely essential [13]. Because future events convey
information that is not available at the time the model is
developed, a model should not be criticised for failing to
predict the future. Therefore, if these or other interven-
tions establish evidences of their own effectiveness, we will
take this new evidence into account for future analyses.
Second, the uncertainties of parameters in the Markov
model could not be ruled out. Although, we examined
the validation with a calibration, the uncertainty could
not be solved perfectly. If future epidemiologic studies
of the Korean population are published, then we could
develop our model with more precision.
Third, when constructing the model of disease progres-
sion, the ‘memoryless problem’ of the Markov assump-
tion could not be solved. When developing the model,
the severity of disease that could differ in accordance
with the disease progression should be considered using
tunnel states. In addition, as mentioned in the Grotel
et al. study, psychological, social and economic factors
that differ among other countries could affect the chroni-
fication of LBP should also be considered in the model-
ling [21]. However, we could not find any appropriate
data for building the tunnel state in the model.
Fourth, we could not avoid the discrepancy of evidence
levels. In the cases of direct non-medical costs and usual
care intervention lists, we had to depend on the low-level
evidence of specialists’ responses and simple hospital cost
data.
Fifth, the heterogeneity of the data may affect the abil-
ity to generalise our findings. We used other countries’
data for the meta-analysis, which could be a caveat to the
full interpretation of effectiveness.
Despite these limitations, we built the Markov model of
chronic LBP and conducted a cost-effectiveness analysis
Kim et al. BMC Complementary and Alternative Medicine 2010, 10:74
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Page 10 of 12of usual care and acupuncture collaboration according to
the reference case analysis methods. Finally, this study
may offer evidence of allocative efficiency concerning the
collaborative treatment of chronic LBP in the 2010 Kor-
ean medical environment.
Conclusions
It is important to provide decision-makers with relevant
information to help them determine if this new colla-
borative treatment strategy should be included in the
National Health Insurance reimbursement list. The
deterministic and sensitivity analyses results showed that
collaborative treatment would be more cost-effective
than usual care alone. Future research is needed to
investigate details using domestic data, which could be
reasonable based on the VOIA results.
Appendices
The Appendices are available in Additional File 1.
Additional material
Additional file 1: Systematic review protocol and Papers included in
the systematic review
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